Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

3-Hydroxybutyric acid (sodium)

3-Hydroxybutyric acid sodium (β-Hydroxybutyric acid sodium) is a metabolite that is elevated in type I diabetes. 3-Hydroxybutyric acid sodium can modulate the properties of membrane lipids[1].

Product Specifications

CAS Number

[150-83-4]

Product Name Alternative

β-Hydroxybutyric acid (sodium)

UNSPSC

12352211

Hazard Statement

H302

Target

Endogenous Metabolite

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease

Applications

Metabolism-sugar/lipid metabolism

Field of Research

Metabolic Disease

Assay Protocol

https://www.medchemexpress.com/3-hydroxybutyric-acid-sodium.html

Purity

99.82

Solubility

DMSO : 16.67 mg/mL (ultrasonic; warming; heat to 60°C) |H2O : 25 mg/mL (ultrasonic; warming; heat to 60°C)

Smiles

CC(O)CC(O[Na])=O

Molecular Formula

C4H7NaO3

Molecular Weight

126.09

Precautions

H302

References & Citations

[1]Hsu TT, et al. 3-Hydroxybutyric acid interacts with lipid monolayers at concentrations that impair consciousness. Langmuir. 2013 Feb 12;29 (6) :1948-55.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, sealed storage, away from moisture)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Isoform

Human Endogenous Metabolite

Citation 01

BMC Neurol. 2025 Apr 10;25 (1) :153.|Research Square Preprint. 2024 Aug 08.|Acta Pharm Sin B. 2025 Mar;15 (3) :1430-1446.|Biochem Biophys Res Commun. 2024 Jul 25:734:150449.|Cancer Cell. 2024 Oct 14;42 (10) :1729-1746.e8.|Cell Host Microbe. 2024 Dec 12:S1931-3128 (24) 00444-X.|Cell Metab. 2023 Jan 3;35 (1) :200-211.e9.|Cells. 2022 Sep 25;11 (19) :2987.|Free Radic Biol Med. 2025 Oct 23:241:914-932.|J Nanobiotechnology. 2022 Mar 9;20 (1) :120.|J Nutr Biochem. 2023 Aug:118:109335.|J Pathol. 2025 Oct 23.|Mol Cell. 2023 Sep 7;83 (17) :3171-3187.e7.|Nat Commun. 2025 May 7;16 (1) :4224.|Nat Metab. 2025 Jul;7 (7) :1330-1343.|Nat Protoc. 2024 May;19 (5) :1311-1347.|Pharmaceuticals (Basel) . 2025 Feb 6;18 (2) :219.|Redox Biol. 2024 May 16.|Signal Transduct Target Ther. 2024 Dec 30;9 (1) :367.

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

MRP-L35 discontinued
347857-01 100 µL

MRP-L35 discontinued

Sign In for Pricing
View Details
MRP-L35 discontinued
347857-02 200 µL

MRP-L35 discontinued

Sign In for Pricing
View Details
SLC22A6 CRISPR All-in-one AAV vector set (with saCas9)(Human)
43963151 3x 1.0 µg DNA

SLC22A6 CRISPR All-in-one AAV vector set (with saCas9)(Human)

Sign In for Pricing
View Details
TBC1D15 Antibody, FITC conjugated
A62164-50UG 50 µg

TBC1D15 Antibody, FITC conjugated

Sign In for Pricing
View Details
SIX1 sgRNA CRISPR Lentivector set (Human)
K2152601 3x 1.0 µg

SIX1 sgRNA CRISPR Lentivector set (Human)

Sign In for Pricing
View Details
KIF3B Antibody (N-term) Blocking Peptide
MBS9222406-01 0.5 mg

KIF3B Antibody (N-term) Blocking Peptide

Sign In for Pricing
View Details